Compare SHC & FHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHC | FHI |
|---|---|---|
| Founded | 2015 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.5B |
| IPO Year | 2020 | 1998 |
| Metric | SHC | FHI |
|---|---|---|
| Price | $18.94 | $62.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $20.33 | ★ $54.20 |
| AVG Volume (30 Days) | ★ 2.6M | 436.9K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.41% |
| EPS Growth | ★ 68.75 | 58.82 |
| EPS | 0.28 | ★ 2.65 |
| Revenue | ★ $1,163,617,000.00 | $1,102,924,000.00 |
| Revenue This Year | $7.51 | $9.90 |
| Revenue Next Year | $6.00 | $4.35 |
| P/E Ratio | $67.32 | ★ $23.21 |
| Revenue Growth | ★ 5.74 | N/A |
| 52 Week Low | $13.09 | $46.66 |
| 52 Week High | $19.85 | $67.20 |
| Indicator | SHC | FHI |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 44.09 |
| Support Level | $18.39 | $54.24 |
| Resistance Level | $19.79 | $67.20 |
| Average True Range (ATR) | 0.44 | 1.29 |
| MACD | -0.10 | -0.55 |
| Stochastic Oscillator | 34.33 | 15.56 |
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
Federated Hermes provides asset management services for institutional and individual investors. The firm had $907.1 billion in managed assets at the end of the first quarter of 2026, composed of equity (11%), multi-asset (less than 1%), fixed-income (11%), alternative (2%), and money market (75%) funds. The company's cash management operations are expected to generate around 53% of Federated's revenue this year, compared with 30%, 10%, and 7%, respectively, for the equity, fixed-income, and alternatives/multi-asset/other operations. The company's products are distributed via trust banks, wealth managers, and retail broker/dealers (67% of AUM), institutional investors (26%), and international clients (7%).